Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 3
2008 1
2010 1
2011 1
2012 2
2013 1
2014 2
2015 1
2017 3
2018 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
Polyunsaturated fatty acids in emerging psychosis.
Mossaheb N, Schloegelhofer M, Schaefer MR, Fusar-Poli P, Smesny S, McGorry P, Berger G, Amminger GP. Mossaheb N, et al. Among authors: schloegelhofer m. Curr Pharm Des. 2012;18(4):576-91. doi: 10.2174/138161212799316055. Curr Pharm Des. 2012. PMID: 22239591 Review.
Genetic association signal near NTN4 in Tourette syndrome.
Paschou P, Yu D, Gerber G, Evans P, Tsetsos F, Davis LK, Karagiannidis I, Chaponis J, Gamazon E, Mueller-Vahl K, Stuhrmann M, Schloegelhofer M, Stamenkovic M, Hebebrand J, Noethen M, Nagy P, Barta C, Tarnok Z, Rizzo R, Depienne C, Worbe Y, Hartmann A, Cath DC, Budman CL, Sandor P, Barr C, Wolanczyk T, Singer H, Chou IC, Grados M, Posthuma D, Rouleau GA, Aschauer H, Freimer NB, Pauls DL, Cox NJ, Mathews CA, Scharf JM. Paschou P, et al. Among authors: schloegelhofer m. Ann Neurol. 2014 Aug;76(2):310-5. doi: 10.1002/ana.24215. Epub 2014 Jul 21. Ann Neurol. 2014. PMID: 25042818 Free PMC article.
The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.
McHugh MJ, McGorry PD, Yuen HP, Hickie IB, Thompson A, de Haan L, Mossaheb N, Smesny S, Lin A, Markulev C, Schloegelhofer M, Wood SJ, Nieman D, Hartmann JA, Nordentoft M, Schäfer M, Amminger GP, Yung A, Nelson B. McHugh MJ, et al. Among authors: schloegelhofer m. Schizophr Res. 2018 May;195:543-548. doi: 10.1016/j.schres.2017.09.003. Epub 2017 Oct 19. Schizophr Res. 2018. PMID: 29055567
Rare Copy Number Variants in NRXN1 and CNTN6 Increase Risk for Tourette Syndrome.
Huang AY, Yu D, Davis LK, Sul JH, Tsetsos F, Ramensky V, Zelaya I, Ramos EM, Osiecki L, Chen JA, McGrath LM, Illmann C, Sandor P, Barr CL, Grados M, Singer HS, Nöthen MM, Hebebrand J, King RA, Dion Y, Rouleau G, Budman CL, Depienne C, Worbe Y, Hartmann A, Müller-Vahl KR, Stuhrmann M, Aschauer H, Stamenkovic M, Schloegelhofer M, Konstantinidis A, Lyon GJ, McMahon WM, Barta C, Tarnok Z, Nagy P, Batterson JR, Rizzo R, Cath DC, Wolanczyk T, Berlin C, Malaty IA, Okun MS, Woods DW, Rees E, Pato CN, Pato MT, Knowles JA, Posthuma D, Pauls DL, Cox NJ, Neale BM, Freimer NB, Paschou P, Mathews CA, Scharf JM, Coppola G; Tourette Syndrome Association International Consortium for Genetics (TSAICG); Gilles de la Tourette Syndrome GWAS Replication Initiative (GGRI). Huang AY, et al. Among authors: schloegelhofer m. Neuron. 2017 Jun 21;94(6):1101-1111.e7. doi: 10.1016/j.neuron.2017.06.010. Neuron. 2017. PMID: 28641109 Free PMC article.
Brain-derived neurotrophic factor (BDNF)-epigenetic regulation in unipolar and bipolar affective disorder.
Carlberg L, Scheibelreiter J, Hassler MR, Schloegelhofer M, Schmoeger M, Ludwig B, Kasper S, Aschauer H, Egger G, Schosser A. Carlberg L, et al. Among authors: schloegelhofer m. J Affect Disord. 2014 Oct;168:399-406. doi: 10.1016/j.jad.2014.07.022. Epub 2014 Jul 19. J Affect Disord. 2014. PMID: 25106037
Changes in triglyceride levels in ultra-high risk for psychosis individuals treated with omega-3 fatty acids.
Mossaheb N, Papageorgiou K, Schäfer MR, Becker J, Schloegelhofer M, Amminger GP. Mossaheb N, et al. Among authors: schloegelhofer m. Early Interv Psychiatry. 2018 Feb;12(1):30-36. doi: 10.1111/eip.12275. Epub 2015 Sep 11. Early Interv Psychiatry. 2018. PMID: 26362578 Clinical Trial.
Duration of untreated psychosis in a high-income versus a low- and middle-income region.
Mossaheb N, Schloegelhofer M, Kaufmann RM, Werneck-Rohrer S, Zehetmayer S, Malik F, Khawar R, Chaudry HR, Amminger GP, Klier CM, Aschauer H. Mossaheb N, et al. Among authors: schloegelhofer m. Aust N Z J Psychiatry. 2013 Dec;47(12):1176-82. doi: 10.1177/0004867413504472. Epub 2013 Sep 24. Aust N Z J Psychiatry. 2013. PMID: 24065694
Usefulness of the CAPE-P15 for detecting people at ultra-high risk for psychosis: Psychometric properties and cut-off values.
Bukenaite A, Stochl J, Mossaheb N, Schäfer MR, Klier CM, Becker J, Schloegelhofer M, Papageorgiou K, Montejo AL, Russo DA, Jones PB, Perez J, Amminger GP. Bukenaite A, et al. Among authors: schloegelhofer m. Schizophr Res. 2017 Nov;189:69-74. doi: 10.1016/j.schres.2017.02.017. Epub 2017 Feb 27. Schizophr Res. 2017. PMID: 28254243
The Community Assessment of Psychic Experience (CAPE) questionnaire as a screening-instrument in the detection of individuals at ultra-high risk for psychosis.
Mossaheb N, Becker J, Schaefer MR, Klier CM, Schloegelhofer M, Papageorgiou K, Amminger GP. Mossaheb N, et al. Among authors: schloegelhofer m. Schizophr Res. 2012 Nov;141(2-3):210-4. doi: 10.1016/j.schres.2012.08.008. Epub 2012 Sep 15. Schizophr Res. 2012. PMID: 22986044
Tourette's syndrome is not associated with interleukin-10 receptor 1 variants on chromosome 11q23.3.
Kindler J, Schosser A, Stamenkovic M, Schloegelhofer M, Leisch F, Hornik K, Aschauer H, Gasche C. Kindler J, et al. Among authors: schloegelhofer m. Psychiatry Res. 2008 Jan 15;157(1-3):235-9. doi: 10.1016/j.psychres.2007.07.021. Epub 2007 Oct 24. Psychiatry Res. 2008. PMID: 17961716
14 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback